Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin vs corticosteroid for persistent post-surgical scar pain
2024-518954-18-01Phase 4Suspended
- Sponsor
- Mater Misericordiae University Hospital
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative pain comparing Botulinum toxin type A + bupivacaine with Triamcinolone acetonide (Adcortyl) + bupivacaine (2 arms). Primary endpoint: Numerical Rating Scale of pain (NRS). Started Dec 2024; status: suspended.
02
Drugs
botulinum toxin type Atriamcinolone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2024-518954-18-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518954-18-01.